Improving Lung Function in Severe Heterogenous Emphysema with the Spiration Valve System (EMPROVE). A Multicenter, Open-Label Randomized Controlled Clinical Trial

J. Criner, Gerard; Delage, Antoine; Voelker, Kirk; Kyle Hogarth, D.; Majid, Adnan; Zgoda, Michael; R. Lazarus, Donald; F. Casal, Roberto; Benzaquen, Sadia; Holladay, Robert; Wellikoff, Adam; Calero, Karel; J. Rumbak, Mark; Branca, Paul; Abu‐Hijleh, Muhanned; M. Mallea, Jorge; Kalhan, Ravi; Sachdeva, Ashutosh; Matthew Kinsey, C.; Lamb, Carla; F. Reed, Michael; Abouzgheib, Wissam; V. Kaplan, Phillip; X. Marrujo, Gregory; W. Johnstone, David; Gasparri, Mario; A. Meade, Arturo; A. Hergott, Christopher; Reddy, Chakravarthy; A. Mularski, Richard; Hajari Case, Amy; Makani, Samir; W. Shepherd, Ray; Chen, Benson; E. Holt, Gregory; Martel, Simon

doi:10.1164/rccm.201902-0383oc

Public

Improving Lung Function in Severe Heterogenous Emphysema with the Spiration Valve System (EMPROVE). A Multicenter, Open-Label Randomized Controlled Clinical Trial

Published in American Journal of Respiratory and Critical Care Medicine • Jul 31, 2019

Authors:

Gerard J. Criner

Antoine Delage

Kirk Voelker

Abstract

Abstract Rationale Less invasive, nonsurgical approaches are needed to treat severe emphysema. Objectives To evaluate the effectiveness and safety of the Spiration Valve System (SVS) versus optimal medical management. Methods In this multicenter, open-label, randomized, controlled trial, subjects ag...

Subject

Medicine

Lung function

Randomized controlled trial

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!